NF-κB antiapoptosis:: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

被引:2460
作者
Wang, CY [1 ]
Mayo, MW
Korneluk, RG
Goeddel, DV
Baldwin, AS
机构
[1] Univ N Carolina, Sch Dent, Lineberger Comprehens Canc Ctr, Dept Endodont, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA
[3] Childrens Hosp Eastern Ontario, Mol Genet Res Lab, Ottawa, ON K1H 8M5, Canada
[4] Tularik, S San Francisco, CA 94080 USA
[5] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1126/science.281.5383.1680
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tumor necrosis factor alpha (TNF-alpha) binding to the TNF receptor (TNFR) potentially initiates apoptosis and activates the transcription factor nuclear factor kappa B (NF-kappa B), which suppresses apoptosis by an unknown mechanism. The activation of NF-kappa B was found to block the activation of caspase-8. TRAF1 (TNFR-associated factor 1), TRAF2, and the inhibitor-of-apoptosis (IAP) proteins c-IAP1 and c-IAP2 were identified as gene targets of NF-kappa B transcriptional activity. in cells in which NF-kappa B was inactive, all of these proteins were required to fully suppress TNF-induced apoptosis, whereas c-IAP1 and c-IAP2 were sufficient to suppress etoposide-induced apoptosis. Thus, NF-kappa B activates a group of gene products that function cooperatively at the earliest checkpoint to suppress TNF-alpha-mediated apoptosis and that function more distally to suppress genotoxic agent-mediated apoptosis.
引用
收藏
页码:1680 / 1683
页数:4
相关论文
共 50 条
  • [31] Competition between TRAF2 and TRAF6 Regulates NF-κB Activation in Human B Lymphocytes
    Amrie C. Grammer
    Peter E. Lipsky
    ChineseMedicalSciencesJournal, 2010, 25 (01) : 1 - 12
  • [32] In TNF-stimulated Cells, RIPK1 Promotes Cell Survival by Stabilizing TRAF2 and cIAP1, which Limits Induction of Non-canonical NF-κB and Activation of Caspase-8
    Gentle, Ian E.
    Wong, W. Wei-Lynn
    Evans, Joseph M.
    Bankovacki, Alexandra
    Cook, Wendy D.
    Khan, Nufail R.
    Nachbur, Ulrich
    Rickard, James
    Anderton, Holly
    Moulin, Maryline
    Lluis, Josep Maria
    Moujalled, Donia M.
    Silke, John
    Vaux, David L.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (15) : 13282 - 13291
  • [33] Immunohistochemical study of NF-κB p65, c-IAP2 and caspase-3 expression in cervical cancer
    Xia, Li
    Xue, Xiu-Zhen
    ONCOLOGY LETTERS, 2012, 3 (04) : 839 - 844
  • [34] Two distinct signalling cascades target the NF-κB regulatory factor c-IAP1 for degradation
    Csomos, Rebecca A.
    Wright, Casey W.
    Galban, Stefanie
    Oetjen, Karolyn A.
    Duckett, Colin S.
    BIOCHEMICAL JOURNAL, 2009, 420 : 83 - 91
  • [35] TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-κB activation
    He, LS
    Grammer, AC
    Wu, XL
    Lipsky, PE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (53) : 55855 - 55865
  • [36] Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: Role in NF-kappa B activation
    Devergne, O
    Hatzivassiliou, E
    Izumi, KM
    Kaye, KM
    Kleijnen, MF
    Kieff, E
    Mosialos, G
    MOLECULAR AND CELLULAR BIOLOGY, 1996, 16 (12) : 7098 - 7108
  • [37] JNK-binding protein 1 regulates NF-κB activation through TRAF2 and TAK1
    Yamaguchi, Tadayuki
    Miyashita, Chiaki
    Koyano, Satoru
    Kanda, Hiromi
    Yoshioka, Katsuji
    Shiba, Tadayoshi
    Takamatsu, Nobuhiko
    Ito, Michihiko
    CELL BIOLOGY INTERNATIONAL, 2009, 33 (03) : 364 - 368
  • [38] NF-κB,c-IAP2,Caspase-3在宫颈癌中的研究进展
    夏丽
    薛秀珍
    河南科技大学学报(医学版), 2010, 28 (02) : 157 - 160
  • [39] TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1
    Etemadi, Nima
    Chopin, Michael
    Anderton, Holly
    Tanzer, Maria C.
    Rickard, James A.
    Abeysekera, Waruni
    Hall, Cathrine
    Spall, Sukhdeep K.
    Wang, Bing
    Xiong, Yuquan
    Hla, Timothy
    Pitson, Stuart M.
    Bonder, Claudine S.
    Wong, Wendy Wei-Lynn
    Ernst, Matthias
    Smyth, Gordon K.
    Vaux, David L.
    Nutt, Stephen L.
    Nachbur, Ueli
    Silke, John
    ELIFE, 2015, 4
  • [40] Targeting the SCAP factors c-IAP1, c-IAP2 and Bcl-2 eliminates senescent cells and enhances TMZ-induced cell killing of glioblastoma cells
    Schwarzenbach, C.
    Tatsch, L.
    Kaina, B.
    Tomicic, M.
    Christmann, M.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (SUPPL 1) : S30 - S30